There are three main molecular subtypes of the breast cancer, which are guiding to choose the best treatment option for the patients: hormone receptor–positive breast cancer, HER2-positive breast cancer, and triple negative breast cancer. Here, NR4A1 is linked to triple-negative breast carcinoma.